COLUSA MEDICAL CENTER
1. Target Overview & Investment Thesis
COLUSA MEDICAL CENTER is a 42-bed under-performing / distressed in COLUSA, CA with $26.2M in net patient revenue and a -28.7% operating margin. The hospital serves a payer mix of 47.9% Medicare, 5.4% Medicaid, and 46.6% commercial.
Thesis: Turnaround. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -28.7% to -21.3% (+736bps).
| Net Revenue HCRIS | $26.2M |
| Current EBITDA COMPUTED | $-7.5M |
| Operating Margin COMPUTED | -28.7% |
| Occupancy HCRIS | 35.2% |
| Revenue / Bed COMPUTED | $623K |
| Net-to-Gross HCRIS | 36.9% |
| Distress Probability ML | 54.2% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -28.7% places it below the state median. Among 96 size-comparable peers (21-84 beds), the median margin is -5.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (21-84), prioritizing same-state peers. 96 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| COLUSA MEDICAL CENTER (Target) | CA | 42 | $26.2M | -28.7% |
| RANCHO LOS AMIGOS NATL.REHAB.C | CA | 83 | $512.6M | 41.9% |
| USC NORRIS CANCER HOSPITAL | CA | 60 | $468.7M | 19.1% |
| ADVENTIST HEALTH SONORA | CA | 84 | $274.3M | -7.4% |
| TAHOE FOREST HOSPITAL | CA | 25 | $264.3M | 13.0% |
| WOODLAND HEALTHCARE | CA | 74 | $211.5M | -3.2% |
| SUTTER AUBURN FAITH HOSPITAL | CA | 64 | $189.3M | 3.8% |
| ADVENTIST HEALTH REEDLEY | CA | 49 | $187.1M | 1.8% |
| SUTTER DAVIS HOSPITAL | CA | 48 | $176.9M | 12.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $549K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $523K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $518K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $318K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $17K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-7.5M |
| + RCM Uplift | +$1.9M |
| Pro Forma EBITDA | $-5.6M |
| Current Margin | -28.7% |
| Pro Forma Margin | -21.3% |
| WC Released (1x) | $1.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-11.6M | $-30.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-11.6M | $-37.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-10.4M | $-34.4M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-10.4M | $-40.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-12.7M | $-36.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-12.7M | $-43.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 54.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 96 hospitals with 21-84 beds
- Same-state prioritization (n=97)
- Comp margins: P25=-18.7% / P50=-5.7% / P75=1.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.